Precigen’s (PGEN) “Overweight” Rating Reiterated at Cantor Fitzgerald
Cantor Fitzgerald reaffirmed their overweight rating on shares of Precigen (NASDAQ:PGEN – Free Report) in a research note issued to investors on Thursday morning,Benzinga reports. Separately, HC Wainwright reissued a “buy” rating and issued a $6.00 price objective on shares of Precigen in a research note on Thursday, March 20th. One equities research analyst has […]
Cantor Fitzgerald reaffirmed their overweight rating on shares of Precigen (NASDAQ:PGEN – Free Report) in a research note issued to investors on Thursday morning,Benzinga reports. Separately, HC Wainwright reissued a “buy” rating and issued a $6.00 price objective on shares of Precigen in a research note on Thursday, March 20th. One equities research analyst has […]
